PTCH1 mutations reported for BCNS patients are predominantly nonsense or frameshift mutations (64%), followed in frequency by splice site mutations (13%), large insertions or deletions (12%), and missense mutations (8%) [21]. Here, PTCH1 is linked to nevoid basal cell carcinoma syndrome.